EDAP TMS reported EUR37.51M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AngioDynamics USD 71.96M 3.68M Sep/2025
Boston Scientific USD 6.43B 1.86B Jun/2026
EDAP TMS EUR 37.51M 6.1M Mar/2026
Henry Schein USD 3.49B 191M Jun/2026
Medtronic USD 11.8B 141M Jun/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Veracyte USD 62.74M 6.62M Jun/2026